| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc. (VNDA) has 1 insider with recent SEC Form 4 filings, including 12 buys and 8 sells. VNDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.34M | $14.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2015 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Buy | 1,201,364 | $8.38 | $10,063,274.25 | +5.6% | |
| Sep 10, 2015 | Polymeropoulos Mihael Hristos77 | President And CEO | Sale+OE | 131,739 | $12.68 | $1,670,486.44 | -7.7% | |
| May 22, 2015 | Polymeropoulos Mihael Hristos77 | President And CEO | Sale+OE | 186,395 | $10.36 | $1,931,337.04 | -12.3% | |
| Mar 10, 2015 | Kelly James Patrick | SVP, CFO, Sec &Treasurer | Sale+OE | 12,450 | $10.53 | $131,098.50 | -18.9% | |
| Mar 10, 2015 | Polymeropoulos Mihael Hristos77 | President And CEO | Sale+OE | 21,900 | $10.53 | $230,607.00 | -3.8% | |
| Mar 10, 2015 | Baroldi Paolo | SVP &Chief Medical Officer | Sale+OE | 8,940 | $10.54 | $94,227.60 | -22.6% | |
| Mar 9, 2015 | Dugan Richard W | Director | Sale+OE | 4,804 | $10.69 | $51,335.06 | -45.4% |